Switzerland-based skincare company Galderma, owned by Nestle, is betting big on its range of anti-ageing injectables and expect to capture a substantial share in India's booming beauty market.
"Our range of Restylane vital skin boosters is getting encouraging response in India. The company will soon launch a new range of products in this segment," Scott Mclennan, Head of Regional Centre of Excellence (Asia-Pacific), Galderma, said here.
He said the company expects to further strengthen its presence in the Indian aesthetic market with this product range.
The size of the beauty care industry in India was estimated at Rs 29,000 crore in 2012.
Mclennan also said the company has started academies in Mumbai and New Delhi to provide training to doctors in aesthetic medicines.
"There is a huge demand in India as the sector is still in the infant stage in the country but we see huge opportunities. As this area needs precision, we have started training doctors," he said.
He said the number of practitioners in India is low as compared to other developing countries like Korea.
"In India, there are only 800 doctors who are practising aesthetic medicine. On the other hand, in Korea the number is 6,000. This means, a huge market is there in India which we can tap," he told reporters.
The demand for dermal fillers and other aesthetic treatments is increasing rapidly in India, Galderma India Head (Aesthetic and Corrective Business) Madhusudhan H K said.
"The academy will help in honing their skills in latest treatment in facial enhancement through dermal fillers. At the academy, our experts will conduct round the year training sessions to meet the requirements of Indian medical aesthetic practitioners," he added.
The firm aims at around five-fold growth in sales to Rs 500 crore by 2018 in its dermatology business in India.
The company, which has manufacturing units in the US, France, mainly imports its products and sells in India.
